Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Miriam T. Jacobs · SciRah

Researcher profile · Semantic Scholar

Miriam T. Jacobs

Share profile

Miriam T. Jacobs — researcher profile on SciRah

h-index: 18
Works: 42
Citations: 1,811

Most-cited papers

Mechanism for alternating access in neurotransmitter transporters
L. Forrest, Yuan-Wei Zhang, Miriam T. Jacobs, J. Gesmonde +3 more
2008Proceedings of the National Academy of Sciences of the United States of America372 citations Open access
Semantic Scholar
Allogeneic natural killer cell therapy
M. Berrien-Elliott, Miriam T. Jacobs, T. Fehniger
2022Blood207 citations Open access
Semantic Scholar
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, P. Jain, F. Locke, M. Maurer +25 more
2023Journal of Clinical Oncology157 citations Open access
Semantic Scholar
Ibogaine, a Noncompetitive Inhibitor of Serotonin Transport, Acts by Stabilizing the Cytoplasm-facing State of the Transporter*
Miriam T. Jacobs, Yuan-Wei Zhang, Scott D. Campbell, G. Rudnick
2007Journal of Biological Chemistry133 citations Open access
Semantic Scholar
Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel.
J. Spiegel, S. Dahiya, Michael D. Jain, J. Tamaresis +22 more
2020Blood128 citations Open access
Semantic Scholar
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
M. Berrien-Elliott, J. Foltz, D. Russler-Germain, C. Neal +36 more
2022Science Translational Medicine105 citations Open access
Semantic Scholar
Genomic Landscape of Appendiceal Neoplasms.
C. Ang, J. Shen, Camille Hardy-Abeloos, Justin K. Huang +12 more
2018JCO Precision Oncology100 citations Open access
Semantic Scholar
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
M. Berrien-Elliott, M. Becker-Hapak, A. Cashen, Miriam T. Jacobs +19 more
2021Blood99 citations Open access
Semantic Scholar
Five Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-cell Lymphoma: Results from the US Lymphoma CAR T Consortium
M. Jain, J. Spiegel, L. Nastoupil, J. Tamaresis +28 more
2024Journal of Clinical Oncology69 citations Open access
Semantic Scholar
Memory-like differentiation enhances NK cell responses to melanoma
Nancy D. Marin, B. Krasnick, M. Becker-Hapak, L. Conant +16 more
2021Clinical Cancer Research54 citations Open access
Semantic Scholar
T-BET and EOMES sustain mature human NK cell identity and antitumor function
Pamela Wong, J. Foltz, Li-Wei Chang, C. Neal +24 more
2023Journal of Clinical Investigation49 citations Open access
Semantic Scholar
Characteristics and Outcomes of Patients Receiving Bridging Therapy While Awaiting Manufacture of Standard of Care Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
M. Jain, Miriam T. Jacobs, L. Nastoupil, J. Spiegel +22 more
2019Blood47 citations Open access
Semantic Scholar
Real‐world evidence of the safety and survival with CD19 CAR‐T cell therapy for relapsed/refractory solid organ transplant‐related PTLD
M. McKenna, N. Epperla, A. Ghobadi, Jie-Qi Liu +13 more
2023British Journal of Haematology38 citations Open access
Semantic Scholar
A Conserved Asparagine Residue in Transmembrane Segment 1 (TM1) of Serotonin Transporter Dictates Chloride-coupled Neurotransmitter Transport*
L. Henry, H. Iwamoto, Julie R. Field, Kristian W. Kaufmann +13 more
2011Journal of Biological Chemistry37 citations Open access
Semantic Scholar
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium
M. Jain, Miriam T. Jacobs, Feng Gao, L. Nastoupil +22 more
2023Blood Advances35 citations Open access
Semantic Scholar
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
Miriam Y. Kim, M. Cooper, Miriam T. Jacobs, Julie Ritchey +3 more
2021JCI Insight35 citations Open access
Semantic Scholar
The use of ruxolitinib for acute graft‐versus‐host disease developing after solid organ transplantation
Miriam T. Jacobs, M. Olson, B. P. Ferreira, Ramon U. Jin +6 more
2020American Journal of Transplantation27 citations Open access
Semantic Scholar
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
Miriam T. Jacobs, M. Jain, F. Gao, L. Nastoupil +22 more
2022Clinical Lymphoma, Myeloma & Leukemia24 citations
Semantic Scholar
Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
J. Spiegel, M. Jain, L. Nastoupil, J. Tamaresis +28 more
2023Blood15 citations Open access
Semantic Scholar
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series.
Miriam T. Jacobs, N. Mohindra, L. Shantzer, I. Chen +10 more
2018JCO Precision Oncology14 citations
Semantic Scholar
Memory-like differentiation, tumor targeting monoclonal antibodies, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer
Miriam T. Jacobs, Pamela Wong, A. Zhou, M. Becker-Hapak +23 more
2023Clinical Cancer Research11 citations Open access
Semantic Scholar
Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium
Yucai Wang, P. Jain, F. Locke, Javier L. Munoz +22 more
2021Blood11 citations Open access
Semantic Scholar
Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation
Celia C. Cubitt, Pamela Wong, Hannah K. Dorando, J. Foltz +15 more
2024Journal of Clinical Investigation10 citations Open access
Semantic Scholar
Memory-like differentiation enhances NK cell responses against colorectal cancer
Nancy D. Marin, M. Becker-Hapak, Wilbur Song, Q. Alayo +17 more
2024Oncoimmunology9 citations Open access
Semantic Scholar
Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: Real-world experience from the United States lymphoma CAR T consortium.
P. Jain, Yucai Wang, F. Locke, J. Muñoz +13 more
2022Journal of Clinical Oncology6 citations
Semantic Scholar
Long-Term Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
J. Spiegel, M. Jain, L. Nastoupil, J. Tamaresis +24 more
2021Blood6 citations Open access
Semantic Scholar
Real World Evidence (RWE) of Safety, Efficacy, and Outcomes of CD19 CAR-T Therapy in 20 Patients with Solid Organ Transplant (SOT)-Related Post-Transplant Lymphoproliferative Disorder (PTLD)
Jie-Qi Liu, Epperla Narendranath, A. Ghobadi, A. Lazaryan +11 more
2021Blood5 citations Open access
Semantic Scholar
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.
Alice Y. Zhou, Nancy D. Marin, Sadia A Afrin, Pamela Wong +24 more
2025Journal of Immunology4 citations
Semantic Scholar
Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
Miriam T. Jacobs, M. Jain, J. Spiegel, L. Nastoupil +22 more
2019Blood3 citations Open access
Semantic Scholar
Somatic mutation landscape of appendiceal cancer.
J. Shen, Miriam T. Jacobs, Ingrid L Fuh, J. Baumgartner +3 more
20183 citations
Semantic Scholar
358 Ramucirumab in combination with pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous-cell carcinoma: a phase 1–2 trial
D. Adkins, J. Ley, K. Palka, Miriam T. Jacobs +2 more
2021Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
Cytokine-Induced Memory-like NK Cells Have a Distinct Single Cell Transcriptional Profile and Persist for Months in Adult and Pediatric Leukemia Patients after Adoptive Transfer
J. Foltz, M. Berrien-Elliott, D. Russler-Germain, C. Neal +24 more
2021Blood2 citations Open access
Semantic Scholar
A CONSERVED ASPARAGINE RESIDUE IN TM 1 OF THE SEROTONIN TRANSPORTER DICTATES CHLORIDE-COUPLED NEUROTRANSMITTER TRANSPORT
L. Henry, H. Iwamoto, Julie R. Field, Kristian W. Kaufmann +13 more
20112 citations
Semantic Scholar
Combination Strategies Enhance NK Cell Therapy for Multiple Myeloma (MM): Memory-like Differentiation, NKG2A Blockade, and Improved Recognition Via BCMA CAR or MM-Targeting Antibodies
Alice Y. Zhou, Nancy D. Marin, Sadia A Afrin, Pamela Wong +24 more
2025Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Abstract 2897: Overcoming barriers to the natural killer cell response against multiple myeloma: Manipulating the NKG2A/HLA-E checkpoint and CAR engineering of memory-like natural killer cells
A. Zhou, M. Berrien-Elliott, R. Vij, M. Fiala +13 more
2023Cancer Research0 citations
Semantic Scholar
Abstract 893: Memory like differentiation enhances in vitro and in vivo NK cell responses against colorectal cancer
Nancy D. Marin, M. Becker-Hapak, Q. Alayo, M. Berrien-Elliot +13 more
2023Cancer Research0 citations
Semantic Scholar
Brief IL-12, IL-15, IL-18 activation drives the acquisition of two distinct memory-like NK cell states
J. Foltz, Jennifer Tran, Bryan Fisk, Pamela Wong +19 more
2023Journal of Immunology0 citations Open access
Semantic Scholar
Abstract 2906: Memory-like differentiation, tumor targeting monoclonal antibodies, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer
Miriam T. Jacobs, Pamela Wong, A. Zhou, M. Becker-Hapak +16 more
2023Cancer Research0 citations
Semantic Scholar
Long-Term Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
Jay Y. Spiegel, Saurabh Dahiya, L. Nastoupil, J. Tamaresis +24 more
2022Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium
Javier Munoz, Yucai Wang, P. Jain, F. Locke +22 more
2022Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Safety, Efficacy, and Outcomes of CD19 CAR T Cell Therapy in 20 Patients with Solid Organ Transplant (SOT)-Related Post-Transplant Lymphoproliferative Disorder (PTLD) in the Real World Setting
Jie-Qi Liu, Epperla Narendranath, A. Ghobadi, A. Lazaryan +11 more
2022Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Does chemoselection open the door for immunotherapy?
Miriam T. Jacobs, A. Ruiz, Ezra E. W. Cohen
2017Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Ghobadi×17
Invite
A. Ghobadi — researcher profile on SciRah
M. Berrien-Elliott×14
Invite
M. Berrien-Elliott — researcher profile on SciRah
T. Fehniger×14
Invite
T. Fehniger — researcher profile on SciRah
Pamela Wong×14
Invite
Pamela Wong — researcher profile on SciRah

M. Becker-Hapak

×14

Invite

M. Becker-Hapak — researcher profile on SciRah

Invite

L. Lekakis — researcher profile on SciRah

Invite

S. Neelapu — researcher profile on SciRah

Invite

J. Foltz — researcher profile on SciRah

Jennifer Tran×13

Invite

Jennifer Tran — researcher profile on SciRah

Nancy D. Marin×13

Invite

Nancy D. Marin — researcher profile on SciRah

Timothy Schappe×13

Invite

Timothy Schappe — researcher profile on SciRah

Lynne Marsala×13

Invite

Lynne Marsala — researcher profile on SciRah